Manufacturing processes of plasma-derived products remove prions

被引：0

作者：

Groener, A. ^{[1
]}

Schaefer, W. ^{[1
]}

机构：

[1] CSL Behring, Virol, Marburg, Germany

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PP-MO-557

引用

页码：508 / 508

页数：1

共 50 条

[1] Influenzaviruses Are Inactivated by the Manufacturing Process of Plasma-Derived Products
Groener, Albrecht
Schaefer, Wolfram
BLOOD, 2009, 114 (22) : 831 - 831
[2] Plasma-derived products: Biological therapeutic products
Follea, G
Cazenave, JP
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1997, 4 (02) : 227 - 240
[3] An industry perspective on plasma-derived products
von Hoegen, I
PDA/EMEA EUROPEAN VIRUS SAFETY FORUM, 2004, 118 : 31 - 35
[4] Plasma-Derived Medicinal Products in Nigeria
Mathew Folaranmi Olaniyan
Musa Abidemi Muhibi
SN Comprehensive Clinical Medicine, 5 (1)
[5] Challenges for Plasma-Derived Medicinal Products
Moog, Rainer
Dehmer-Laitinen, Teija
Taborski, Uwe
TRANSFUSION MEDICINE AND HEMOTHERAPY, 2023, 50 (06) : 559 - 560
[6] Challenges for Plasma-Derived Medicinal Products
Strengers, Paul F. W.
TRANSFUSION MEDICINE AND HEMOTHERAPY, 2023, 50 (02) : 116 - 122
[7] Nanofiltration of plasma-derived biopharmaceutical products
Burnouf, T
Radosevich, M
HAEMOPHILIA, 2003, 9 (01) : 24 - 37
[8] The safety of plasma-derived products in Australia
Guirguis, Andrew
Wood, Erica
AUSTRALIAN PRESCRIBER, 2010, 33 (03) : 76 - 79
[9] Plasma-derived industry and plasma-derived medicinal products in the Italian National Blood Transfusion Service
De Silvestro, Giustina
Marson, Piero
Breda, Antonio
De Angelis, Vincenzo
TRANSFUSION AND APHERESIS SCIENCE, 2019, 58 (05) : 545 - 549
[10] Validation strategies for biopharmaceuticals - Viral validation approaches for plasma-derived biopharmaceutical manufacturing processes
Revie, D
Phelan, M
Losikoff, A
Ziomek, C
GENETIC ENGINEERING NEWS, 1999, 19 (08): : 14 - +

← 1 2 3 4 5 →